MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejso.2024.107953

Медицинская библиотека · European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2024

Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study.

Spierenburg Geert, Staals Eric L, Palmerini Emanuela, Randall Robert Lor, Thorpe Steven W, Wunder Jay S, Ferguson Peter C, Verspoor Floortje G M, Houdek Matthew T, Bernthal Nicholas M, Schreuder Bart H W B, Gelderblom Hans, van de Sande Michiel A J, van der Heijden Lizz

Многоцентровое исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Diffuse-type tenosynovial giant cell tumor (D-TGCT) is a mono-articular, soft-tissue tumor. Although it can behave locally aggressively, D-TGCT is a non-malignant disease. This is the first study describing the natural course of D-TGCT and evaluating active surveillance as possible treatment strategy.

METHODS

This retrospective, multicenter study included therapy naïve patients with D-TGCT from eight sarcoma centers worldwide between 2000 and 2019. Patients initially managed by active surveillance following their first consultation were eligible. Data regarding the radiological and clinical course and subsequent treatments were collected.

RESULTS

Sixty-one patients with primary D-TGCT were initially managed by active surveillance. Fifty-nine patients had an MRI performed around first consultation: D-TGCT was located intra-articular in most patients (n = 56; 95 %) and extra-articular in 14 cases (24 %). At baseline, osteoarthritis was observed in 13 patients (22 %) on MRI. Most of the patients' reported symptoms: pain (n = 43; 70 %), swelling (n = 33; 54 %). Eight patients (13 %) were asymptomatic. Follow-up data were available for 58 patients; the median follow-up was 28 months. Twenty-one patients (36 %) had radiological progression after 21 months (median). Eight of 45 patients (18 %) without osteoarthritis at baseline developed osteoarthritis during follow-up. Thirty-seven patients (64 %) did not clinically deteriorate during follow-up. Finally, eighteen patients (31 %) required a subsequent treatment.

CONCLUSION

Active surveillance can be considered adequate for selected therapy naïve D-TGCT patients. Although follow-up data was limited, almost two-thirds of the patients remained progression-free, and 69 % did not need treatment during the follow-up period. However, one-fifth of patients developed secondary osteoarthritis. Prospective studies on active surveillance are warranted.

Для цитирования: Spierenburg Geert, Staals Eric L, Palmerini Emanuela, Randall Robert Lor, Thorpe Steven W, Wunder Jay S, Ferguson Peter C, Verspoor Floortje G M, Houdek Matthew T, Bernthal Nicholas M, Schreuder Bart H W B, Gelderblom Hans, van de Sande Michiel A J, van der Heijden Lizz. Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2024. DOI: 10.1016/j.ejso.2024.107953.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.